Judi Sakowski December 9, 2024 Two Studies Presented at ASH 2024 Confirm Value of Hemex Health’s Gazelle DiagnosticDevice in National Health Initiatives Focused on Hemoglobin Variants Judi Sakowski December 9, 2024 Release
Judi Sakowski November 13, 2024 Two New Solutions from Hemex Health Empower More Clinicians and Health Workers to Test for Iron Deficiency Anaemia and Sickle Cell Disease Judi Sakowski November 13, 2024 Release
Judi Sakowski October 7, 2024 Researchers Find Gazelle Hb Variant Test Offers Accuracy and Accessibility for Newborn Sickle Cell Disease Screening and Premarital Screening for Beta Thalassemia and Sickle Cell Disease Judi Sakowski October 7, 2024 Press Release
Judi Sakowski June 19, 2024 New Research Confirms Hb Variant Test for Sickle Cell, Gazelle™, Useful for Screening and Tracking Treatment Management in Remote Settings Judi Sakowski June 19, 2024 Press Release
Judi Sakowski February 2, 2024 Study of First Point-of-Care Test for Beta Thalassemia Performs at 99% Accuracy in Diagnosing the Blood Disorder Judi Sakowski February 2, 2024 Press Release
Judi Sakowski October 10, 2023 California State Treasurer, Fiona Ma, and US-India cross-border association, AllianceIndus, congratulate Hemex Health for India partnerships that led to a breakthrough test for sickle cell disease Judi Sakowski October 10, 2023 Press Release
Judi Sakowski May 12, 2023 Eradication of Beta Thalassemia in India “As Soon as Possible” Will Require Low Cost, Accurate Point-of-Care Testing with India-Made Gazelle from HemexDx Judi Sakowski May 12, 2023 Press Release
Judi Sakowski March 27, 2023 Hemex Health Awarded $3M NIH Grant to Bring Gazelle Hb Variant Test for Sickle Cell Disease to US Market Judi Sakowski March 27, 2023 Press Release
Judi Sakowski July 5, 2022 Hemex Health and Mylab Discovery Solutions Launch Gazelle™ PathoCatch™ COVID-19 FIA Test Judi Sakowski July 5, 2022 Press Release
Judi Sakowski May 7, 2022 Hemex Health announces breakthrough measurement capability for Gazelle Diagnostic Device for clinicians monitoring SCD therapy Judi Sakowski May 7, 2022 Press Release
Judi Sakowski November 15, 2021 First Point-of-Care Test for Serious Hemoglobin Disorder, Beta Thalassemia, Provides New Weapon for the Front Lines of Healthcare Worldwide Judi Sakowski November 15, 2021 Press Release
Judi Sakowski October 13, 2021 Researchers from India’s National Institute of Research in Tribal Health Confirm Gazelle’s Ability to Accurately Diagnose Sickle Cell Disease in Remote Regions Judi Sakowski October 13, 2021 Press Release
Judi Sakowski August 9, 2021 Mylab and US-Based Hemex Health Announce Technology Partnership for Point-of-Care Diagnostics Judi Sakowski August 9, 2021 Press Release
